14 | IntegrinsIBA
11/2017
-
05/2009 |
9 | Peptides (Polypeptides)IBA
01/2012
-
05/2009 |
8 | arginyl-glycyl-aspartic acidIBA
02/2012
-
05/2009 |
4 | Integrin alphaVbeta3IBA
02/2010
-
05/2009 |
3 | Monoclonal AntibodiesIBA
06/2015
-
12/2013 |
3 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2014
-
12/2013 |
3 | Coloring Agents (Dyes)IBA
08/2014
-
11/2011 |
2 | Pharmaceutical PreparationsIBA
11/2017
-
01/2015 |
2 | Proteins (Proteins, Gene)FDA Link
02/2016
-
07/2014 |
2 | Endoplasmic Reticulum Chaperone BiPIBA
06/2015
-
12/2013 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2014
-
03/2011 |
2 | CY5.5 cyanine dyeIBA
08/2014
-
12/2013 |
2 | EphB4 ReceptorIBA
07/2013
-
01/2013 |
2 | Phosphates (Orthophosphate)IBA
11/2011
-
01/2011 |
2 | Chelating AgentsIBA
09/2011
-
05/2009 |
2 | AcidsIBA
02/2010
-
08/2009 |
2 | cyclic arginine-glycine-aspartic acid peptideIBA
02/2010
-
06/2009 |
2 | BombesinIBA
07/2009
-
05/2009 |
2 | Bombesin Receptors (Bombesin Receptor)IBA
07/2009
-
05/2009 |
1 | Carrier Proteins (Binding Protein)IBA
11/2017 |
1 | Sirolimus (Rapamycin)FDA Link
11/2017 |
1 | Tacrolimus (Prograf)FDA LinkGeneric
11/2017 |
1 | Elastin-Like PolypeptidesIBA
11/2017 |
1 | Tacrolimus Binding Proteins (FKBP)IBA
11/2017 |
1 | Matrix Metalloproteinases (MMPs)IBA
02/2016 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2016 |
1 | ChemokinesIBA
02/2016 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
02/2016 |
1 | CytokinesIBA
02/2016 |
1 | Immunotoxins (Immunotoxin)IBA
02/2016 |
1 | Immunoglobulin G (IgG)IBA
06/2015 |
1 | RNA (Ribonucleic Acid)IBA
01/2015 |
1 | fluoroazomycin arabinosideIBA
01/2015 |
1 | 1- cyclopropyl- 4- (4- ((5- methyl- 3- (3- (4- (trifluoromethoxy)phenyl)- 1,2,4- oxadiazol- 5- yl)- 1H- pyrazol- 1- yl)methyl)pyridin- 2- yl)piperazineIBA
01/2015 |
1 | DisintegrinsIBA
07/2014 |
1 | PolymersIBA
07/2014 |
1 | Neurotensin Receptors (Neurotensin Receptor)IBA
07/2014 |
1 | Sulfhydryl Compounds (Thiols)IBA
07/2014 |
1 | Rituximab (Mabthera)FDA Link
03/2014 |
1 | Glucagon-Like Peptide-1 ReceptorIBA
01/2014 |
1 | Exenatide (Byetta)FDA Link
01/2014 |
1 | alanyltyrosineIBA
01/2014 |
1 | pyridineIBA
09/2013 |
1 | Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013 |
1 | Melanins (Melanin)IBA
09/2013 |
1 | benzamideIBA
09/2013 |
1 | N,N-diethylethylenediamineIBA
09/2013 |
1 | Molecular Probes (Molecular Probe)IBA
09/2013 |
1 | Benzene (Benzole)IBA
09/2013 |
1 | EphrinsIBA
07/2013 |
1 | AntibodiesIBA
07/2013 |
1 | Liposomes (Liposome)IBA
04/2013 |
1 | picolinamideIBA
02/2013 |
1 | Agouti-Related ProteinIBA
02/2013 |
1 | polypeptide CIBA
02/2013 |
1 | Contrast MediaIBA
01/2013 |
1 | Lewis AcidsIBA
01/2013 |
1 | 4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2013 |
1 | Peptide LibraryIBA
11/2011 |
1 | Biomarkers (Surrogate Marker)IBA
11/2011 |
1 | Bevacizumab (Avastin)FDA Link
11/2011 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2011 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
09/2011 |
1 | AlbuminsIBA
03/2011 |
1 | LigandsIBA
01/2011 |
1 | Investigational DrugsIBA
01/2011 |
1 | Cystine-Knot MiniproteinsIBA
01/2011 |
1 | PeptidomimeticsIBA
01/2011 |
1 | FPP(RGD)2IBA
01/2011 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2011 |
1 | Albumin-Bound PaclitaxelFDA Link
01/2011 |
1 | IRDye800IBA
02/2010 |
1 | Ethylene Glycol (Monoethylene Glycol)IBA
02/2010 |
1 | aspartic acid glycine arginineIBA
02/2010 |
1 | Glutamic Acid (Glutamate)FDA Link
08/2009 |
1 | Cell Surface ReceptorsIBA
07/2009 |
1 | AH 111585IBA
06/2009 |
1 | Radioisotopes (Radionuclides)IBA
05/2009 |
1 | IsotopesIBA
05/2009 |
1 | RadiopharmaceuticalsIBA
05/2009 |